Bronfman gift to Mount Sinai catalyzes genomics-based medicine

New York, NYApril 6, 2007 -- The Andrea and Charles Bronfman Philanthropies (ACBP) have given $12.5 million to establish the Charles Bronfman Institute for Personalized Medicine at The Mount Sinai Medical Center. The Leadership Gift will help propel Mount Sinai to the forefront of personalized medicine, an emerging field that uses information about a persons genetic make-up to customize strategies for the detection, treatment, and prevention of disease. At the highest level, Mr. Bronfmans grant underscores the vital role philanthropy will play in advancing next-generation medical practice.

"Personalized medicine could be the most important scientific development of the 21st century," said Charles Bronfman, Chairman of the Andrea and Charles Bronfman Philanthropies. "In an industry like medicine, where market forces are slow to change, philanthropy must play the role of catalyst facilitating growth, inspiring awareness, and serving as a basis for change. The Mount Sinai Medical Center has been a pacesetter in the area of personalized medicine and is a clear choice for receiving this grant."

Personalized medicine transforms the traditional "one-size-fits-all" model of medicine by utilizing new methods of molecular analysis to better manage a patients disease or predisposition toward a disease. It represents a dramatic departure from "evidence-based medicine," which is based on population studies and has dominated medical principles for decades. While the evidence-based approach does allow doctors to modify treatment strategies according to a particular patient's response, it relies on trial-and-error and lacks precision. Personalized medicine, on the other hand, gives doctors an answer based on an individuals unique set of genes and thereby reduces uncertainty and error in diagnosis and treatment.

"The Mount Sinai Medical Center is poised to lead the most important medical revolution taking place today, and one that will have the big

Contact: Rich Polt
The Mount Sinai Hospital / Mount Sinai School of Medicine

Page: 1 2 3

Related biology news :

1. Climate change isolates Rocky Mountain butterflies
2. Bernese Mountain Dogs prone to Borrelia burgdorferi infection
3. NIH establishes Center of Excellence for influenza research at Mount Sinai
4. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
5. Sensational find: The mini-dinosaurs from the Harz Mountains
6. Brookhaven Lab and Mount Sinai form joint Center for Translational Biomedical Imaging
7. Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine
8. University of Kentucky author captures national attention with Lost Mountain
9. Infectious disease expert warns of spread of Rocky Mountain spotted fever
10. Mount Sinai receives NIH funding for stem cell research
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:

(Date:3/13/2019)... ... March 13, 2019 , ... Leak Detection Associates , the leading global ... Industries, is excited to announce that it will be returning to INTERPHEX ... newly installed and highly experienced management team immediately marked Interphex as the show ...
(Date:3/9/2019)... Calif. (PRWEB) , ... March 07, 2019 , ... ... of a full day workshop presented by University of California Riverside’s EPIC ... held from 8 a.m. to 6 p.m. on Tuesday, March 17, 2019. The location ...
(Date:3/9/2019)... ... March 08, 2019 , ... Ace Laboratories, ... Well-Mints™ resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ). , Well-Mints™ each ... flavored hard candy base dusted with powdered sugar. , Well-Mints'™ patented technology delivers ...
Breaking Biology News(10 mins):
(Date:3/12/2019)... (PRWEB) , ... March 11, 2019 , ... ... first hospital system in Colorado, and among the first in the nation, to ... around lab draws, IV placement and overall degree to which staff showed compassion ...
(Date:3/11/2019)... ... ... In this live webinar, the featured speakers will focus on the many attributes that ... how to use the information they have from the protocol and clinical trial knowledge, ... is properly designed and set up to ensure flawless execution. As clinical trial success ...
(Date:3/9/2019)... SAN DIEGO (PRWEB) , ... March 07, 2019 ... ... Agilent Technologies, is a pioneer in the development and commercialization of high performance, ... and PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and ...
(Date:3/5/2019)... ... March 05, 2019 , ... San Fransisko, or Sisko ... purchased him at four years old to pursue a career in dressage. According ... the most talented horse that she’d ever worked with. Unfortunately, Sisko suffered an ...
Breaking Biology Technology:
Cached News: